Drug Pipeline

ADVATE Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
2
Phase 3
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-30 NCT07446010
Post Approval Observational Study to Learn More About How Safe Octocog Alfa is and How…		 date change Primary completion pushed: 2026-12-31 -> 2027-09-30
2026-05-30 NCT07446010
Post Approval Observational Study to Learn More About How Safe Octocog Alfa is and How…		 date change Completion pushed: 2026-12-31 -> 2027-09-30
Active Studies by Phase
Phase 3
2
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07129343 A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von… Von Willebrand Disease (VWD) Recruiting
NCT05582993 A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD) Von Willebrand Disease (VWD) Recruiting
Phase 2
NCT07069569 A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs Chronic Hepatitis B Recruiting
Not specified
NCT07446010 Post Approval Observational Study to Learn More About How Safe Octocog Alfa is and How… Hemophilia A Not Yet Recruiting
Sponsors Running ADVATE Trials
Takeda (2) Ausper Biopharma Co., Ltd. (1) Bayer (1)
Disease Areas
Hemophilia (1)
Get alerts when ADVATE trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free